News

Photo
07.05.2025 • News

Bionova Licenses Technologies from ATUM

Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), has licensed ATUM’s proprietary Leap-In Transposase transposon-based gene delivery and its miCHO cell line development technologies.

Photo
24.04.2025 • NewsBioprocessing

Fujifilm Diosynth Biotechnologies & Regeneron Sign Manufacturing Agreement

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced a 10-year manufacturing supply agreement, valued at over $3 billion (€2.64 billion), with Regeneron Pharmaceuticals to provide US-based production of its industry-leading biologic medicines, which treat millions of patients worldwide.

Photo
23.04.2025 • News

From Innovation to Implementation

What happens when over 300 pharmaceutical leaders from across Europe and beyond gather in Berlin? Insightful discussions, strategic collaboration and opinions exchange — all under one roof. The 5th edition of the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP), held on 14–15 April, brought together decision-makers from across the pharmaceutical value chain to explore the technologies, trends and innovations shaping drug production and packaging.

Photo
22.04.2025 • News

Suanfarma Appoints Pere Mañé as New CEO

CDMO Suanfarma appoints Pere Mañé Godina as its new CEO, marking the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

13584 more News

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.